Jefferies Revises Models and Price Targets on Life Science Tools, Diagnostics and Dental Companies

August 17, 2016 7:51 AM EDT
Get Alerts CPHD Hot Sheet
Price: $52.93 --0%

Rating Summary:
    13 Buy, 16 Hold, 1 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 17 | Down: 26 | New: 7
Trade CPHD Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

Jefferies revised models & price targets for 5 different Tools/Diagnostics/Dental companies, including: CPHD (PT to $34 from $28), GHDX (PT to $27 from $25), LMNX, OPK, and XRAY.

Analyst Brandon Couillard commented, "We are publishing revised models & price targets for 5 various Life Science Tools, Diagnostics & Dental companies following 2Q16 earnings season, including CPHD, GHDX, OPK, LMNX & XRAY. We are also adjusting our PDCO model ahead of its 1Q17 results next week. Our top picks by sub-sector are: Tools—BIO, BRKR, DHR, VWR; Diagnostics—EXAS, QTNT; Dental—ALGN, XRAY; Tech/Special Sit—KEYS."

For an analyst ratings summary and ratings history on Cepheid click here. For more ratings news on Cepheid click here.

Shares of Cepheid closed at $36.00 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst EPS Change, Analyst PT Change

Related Entities

Jefferies & Co, Earnings

Add Your Comment